Metabolomic prediction of diabetes and cardiovascular risk

Medical Principles and Practice

Volumn 21, Issue 5, 2012, Pages 401-403

  Dagogo Jack, Samuel ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLCARNITINE; AROMATIC AMINO ACID; BILE ACID; BRANCHED CHAIN AMINO ACID; GLUTAMINE; ISOLEUCINE; KETONE BODY; LEUCINE; LIPID; METHIONINE; PHENYLALANINE; PURINE; TYROSINE; VALINE;

ARTICLE; CARDIOMETABOLIC RISK; CARDIOVASCULAR RISK; DIABETOGENESIS; DISEASE PREDISPOSITION; DYSGLYCEMIA; DYSLIPIDEMIA; HUMAN; HYPERTENSION; INSULIN RESISTANCE; METABOLOMICS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOPHYSIOLOGY; PREDICTION; RISK ASSESSMENT; UREA CYCLE;

AMINO ACIDS, AROMATIC; AMINO ACIDS, BRANCHED-CHAIN; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; HUMANS; INSULIN RESISTANCE; METABOLOMICS; RISK ASSESSMENT;

EID: 84865035725     PISSN: 10117571     EISSN: 14230151     Source Type: Journal    
DOI: 10.1159/000339203     Document Type: Article

References (10)

1. Echouffo-Tcheugui JB, Dagogo-Jack S: Preventing diabetes mellitus in developing countries. Nat Rev Endocrinol 2012, E-pub ahead of print.
2. Newgard CB, An J, Bain JR, Muehlbauer MJ, Stevens RD, Lien LF, Haqq AM, Shah SH, Arlotto M, Slentz CA, Rochon J, Gallup D, Ilkayeva O, Wenner BR, Yancy WS, Jr., Eisenson H, Musante G, Surwit RS, Millington DS, Butler MD, Svetkey LP: A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab 2009; 9: 311-326.
3. Dagogo-Jack S, Askari H, Tykodi G: Gluco-regulatory physiology in subjects with low-normal, high-normal, or impaired fasting glucose. J Clin Endocrinol Metab 2009; 94: 2031-2036.
4. Zhao X, Peter A, Fritsche J, Elcnerova M, Fritsche A, Haring H U, Schleicher ED, Xu G, Lehmann R: Changes of the plasma metabo-lome during an oral glucose tolerance test: is there more than glucose to look at? Am J Physiol Endocrinol Metab 2009; 296:E384-E393.
5. Shaham O, Wei R, Wang TJ, Ricciardi C, Lewis GD, Vasan RS, Carr SA, Thadhani R, Gerszten RE, Mootha VK: Metabolic profiling of the human response to a glucose challenge reveals distinct axes of insulin sensitivity. Mol Syst Biol 2008; 4:214.
6. Wang TJ, Larson MG, Vasan RS, Cheng S, Rhee EP, McCabe E, Lewis GD, Fox CS, Jacques PF, Fernandez C, O'Donnell CJ, Carr SA, Mootha VK, Florez JC, Souza A, Melander O, Clish CB, Gerszten RE: Metabolite profiles and the risk of developing diabetes. Nat Med 2011; 17: 448-453.
7. Rhee EP, Cheng S, Larson MG, Walford GA, Lewis GD, McCabe E, Yang E, Farrell L, Fox CS, O'Donnell CJ, Carr SA, Vasan RS, Florez JC, Clish CB, Wang TJ, Gerszten RE: Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans. J Clin Invest 2011;121:1402-1411.
8. Cheng S, Rhee EP, Larson MG, Lewis GD, McCabe EL, Shen D, Palma MJ, Roberts LD, Dejam A, Souza AL, Deik AA, Magnusson M, Fox CS, O'Donnell CJ, Vasan RS, Me-lander O, Clish CB, Gerszten RE, Wang TJ: Metabolite profiling identifies pathways associated with metabolic risk in humans. Circulation 2012;125:2222-2231.
9. Laferrère B, Reilly D, Arias S, Swerdlow N, Gorroochurn P, Bawa B, Bose M, Teixeira J, Stevens RD, Wenner BR, Bain JR, Muehlbau-er MJ, Haqq A, Lien L, Shah SH, Svetkey LP, Newgard CB: Differential metabolic impact of gastric bypass surgery versus dietary intervention in obese diabetic subjects despite identical weight loss. Sci Transl Med 2011; 3: 80re2.
10. Dagogo-Jack S, Egbuonu N, Edeoga C: Principles and practice of nonpharmacological interventions to reduce cardiometabolic risk. Med Princ Pract 2010; 19: 167-175.